| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | — | +21.0% |
| Cost of Revenue | $1.1M | — | +13.8% |
| Gross Profit | $1.7M | — | +26.2% |
| R&D Expense | $156K | — | +54.5% |
| SG&A Expense | $800K | — | -8.2% |
| Operating Income | $442K | — | +220.3% |
| Pre-tax Income | $434K | — | +298.2% |
| Income Tax | $10K | — | — |
| Net Income | $424K | — | +289.0% |
| EPS (Basic) | $0.01 | — | +289.5% |
| EPS (Diluted) | $0.01 | — | +289.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.2M | +405.7% | — |
| Accounts Receivable | $2.9M | +28.0% | — |
| Inventory | $80K | +0.0% | — |
| Current Assets | $10.5M | -3.4% | — |
| Total Assets | $20.1M | -3.5% | — |
| Current Liabilities | $4.2M | -15.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.2M | — | -28.8% |
| Investing Cash Flow | -$132K | — | +0.0% |
| Long-term Debt | $2.7M | +0.0% | — |
| Total Liabilities | $11.4M | -9.5% | — |
| Stockholders' Equity | $8.7M | +5.5% | +27.2% |